Pharmacotherapeutics for Advanced Practice
Nurse Prescribers with Davis Edge
6th Edition
Question 1
Reference: Ch. 1, Section: The Advanced Practice Registered
Nurse (APRN) as Prescriber
Question Stem: A new Family Nurse Practitioner (FNP) is
preparing to enter practice in a state that has adopted full
practice authority for APRNs. Which component is essential for
this FNP to have in place prior to independently prescribing
Schedule II controlled substances?
A) A signed collaborative agreement with a physician in the
same specialty.
B) A state-issued license to practice as an FNP and a federal DEA
registration number.
C) A signed precepting agreement documenting 1,000 hours of
supervised prescribing.
D) Proof of successful completion of an advanced pharmacology
course within the last five years.
Correct Answer: B
Rationales:
• Correct: In states with full practice authority, APRNs are
licensed by the state to practice and prescribe
independently, including controlled substances. A federal
, DEA registration is legally required to prescribe, dispense,
or administer any controlled substance.
• Incorrect A: A collaborative agreement is a requirement in
states with reduced or restricted practice authority, not in
states with full practice authority.
• Incorrect C: While supervised clinical hours are part of
educational preparation, they are not a direct legal
requirement for obtaining a DEA number or state
prescribing license post-licensure.
• Incorrect D: Proof of advanced pharmacology is a
requirement for initial licensure and certification, not an
ongoing legal requirement for each prescription written.
Teaching Point: Full practice authority requires a state license
and a DEA number to prescribe controlled substances.
Citation: Woo, T. M., & Wright, W. L.
(2023). Pharmacotherapeutics for Advanced Practice Nurse
Prescribers with Davis Edge (6th ed.). F.A. Davis. Chapter 1.
Question 2
Reference: Ch. 1, Section: The Advanced Practice Registered
Nurse (APRN) as Prescriber
Question Stem: An APRN is licensed in a state that mandates a
"Collaborative Practice Agreement" for prescriptive authority.
What is the primary legal function of this document?
,A) It allows the APRN to bill insurance independently for
evaluation and management services.
B) It delegates the authority to prescribe from the collaborating
physician to the APRN.
C) It certifies that the APRN has met the educational
requirements for national certification.
D) It grants the APRN hospital admitting privileges within the
affiliated healthcare system.
Correct Answer: B
Rationales:
• Correct: In restricted or reduced practice states, the
collaborative agreement is a legal document that formally
delegates prescriptive authority from a physician to the
APRN, outlining the scope and terms of this delegation.
• Incorrect A: Billing privileges are governed by payer
policies, not directly by a collaborative practice agreement.
• Incorrect C: Educational requirements and national
certification are prerequisites for state licensure, not
functions of a collaborative agreement.
• Incorrect D: Hospital privileges are granted by the
hospital's credentialing committee and are separate from
state-level prescriptive authority agreements.
Teaching Point: Collaborative agreements legally delegate
prescribing authority in restricted practice states.
, Citation: Woo, T. M., & Wright, W. L.
(2023). Pharmacotherapeutics for Advanced Practice Nurse
Prescribers with Davis Edge (6th ed.). F.A. Davis. Chapter 1.
Question 3
Reference: Ch. 1, Section: The Prescribing Process
Question Stem: During the "Therapeutic Decision-Making" step
of the prescribing process, an APRN is considering a medication
for a patient with hypertension. Which action best represents
this step?
A) Writing the prescription and providing patient education.
B) Evaluating the patient's blood pressure response at a follow-
up visit.
C) Gathering data on the patient's renal function and potential
drug interactions.
D) Selecting a specific drug, dose, and formulation based on
patient-specific factors.
Correct Answer: D
Rationales:
• Correct: Therapeutic decision-making involves synthesizing
patient data to select the most appropriate therapeutic
regimen, including the specific drug, dosage, route, and
frequency.
Nurse Prescribers with Davis Edge
6th Edition
Question 1
Reference: Ch. 1, Section: The Advanced Practice Registered
Nurse (APRN) as Prescriber
Question Stem: A new Family Nurse Practitioner (FNP) is
preparing to enter practice in a state that has adopted full
practice authority for APRNs. Which component is essential for
this FNP to have in place prior to independently prescribing
Schedule II controlled substances?
A) A signed collaborative agreement with a physician in the
same specialty.
B) A state-issued license to practice as an FNP and a federal DEA
registration number.
C) A signed precepting agreement documenting 1,000 hours of
supervised prescribing.
D) Proof of successful completion of an advanced pharmacology
course within the last five years.
Correct Answer: B
Rationales:
• Correct: In states with full practice authority, APRNs are
licensed by the state to practice and prescribe
independently, including controlled substances. A federal
, DEA registration is legally required to prescribe, dispense,
or administer any controlled substance.
• Incorrect A: A collaborative agreement is a requirement in
states with reduced or restricted practice authority, not in
states with full practice authority.
• Incorrect C: While supervised clinical hours are part of
educational preparation, they are not a direct legal
requirement for obtaining a DEA number or state
prescribing license post-licensure.
• Incorrect D: Proof of advanced pharmacology is a
requirement for initial licensure and certification, not an
ongoing legal requirement for each prescription written.
Teaching Point: Full practice authority requires a state license
and a DEA number to prescribe controlled substances.
Citation: Woo, T. M., & Wright, W. L.
(2023). Pharmacotherapeutics for Advanced Practice Nurse
Prescribers with Davis Edge (6th ed.). F.A. Davis. Chapter 1.
Question 2
Reference: Ch. 1, Section: The Advanced Practice Registered
Nurse (APRN) as Prescriber
Question Stem: An APRN is licensed in a state that mandates a
"Collaborative Practice Agreement" for prescriptive authority.
What is the primary legal function of this document?
,A) It allows the APRN to bill insurance independently for
evaluation and management services.
B) It delegates the authority to prescribe from the collaborating
physician to the APRN.
C) It certifies that the APRN has met the educational
requirements for national certification.
D) It grants the APRN hospital admitting privileges within the
affiliated healthcare system.
Correct Answer: B
Rationales:
• Correct: In restricted or reduced practice states, the
collaborative agreement is a legal document that formally
delegates prescriptive authority from a physician to the
APRN, outlining the scope and terms of this delegation.
• Incorrect A: Billing privileges are governed by payer
policies, not directly by a collaborative practice agreement.
• Incorrect C: Educational requirements and national
certification are prerequisites for state licensure, not
functions of a collaborative agreement.
• Incorrect D: Hospital privileges are granted by the
hospital's credentialing committee and are separate from
state-level prescriptive authority agreements.
Teaching Point: Collaborative agreements legally delegate
prescribing authority in restricted practice states.
, Citation: Woo, T. M., & Wright, W. L.
(2023). Pharmacotherapeutics for Advanced Practice Nurse
Prescribers with Davis Edge (6th ed.). F.A. Davis. Chapter 1.
Question 3
Reference: Ch. 1, Section: The Prescribing Process
Question Stem: During the "Therapeutic Decision-Making" step
of the prescribing process, an APRN is considering a medication
for a patient with hypertension. Which action best represents
this step?
A) Writing the prescription and providing patient education.
B) Evaluating the patient's blood pressure response at a follow-
up visit.
C) Gathering data on the patient's renal function and potential
drug interactions.
D) Selecting a specific drug, dose, and formulation based on
patient-specific factors.
Correct Answer: D
Rationales:
• Correct: Therapeutic decision-making involves synthesizing
patient data to select the most appropriate therapeutic
regimen, including the specific drug, dosage, route, and
frequency.
